News Releases

Date Title

July 2019

Grassley On Treasury, Tax Court Nominations Open Executive Session
Grassley On Ensuring Brand Name Drugs Pay Brand Name Rebates
Grassley Presses DoD IG to Audit TransDigm Business Model
Grassley: Goldilocks Moment to Reduce Rx Prices
Grassley, Senators Seek Updates & Further Action on Justice Department Efforts to Clarify Website Accessibility Under ADA
Grassley Urges Esper in Handwritten Note to Commit to Fiscal Responsibility, Reform at DoD
Congress Passes Grassley Legislation to Help Children with Special Health Care Needs
ICYMI: Libertarian Cato Institute Supports Finance Committee’s Medicare Part D Reforms
Grassley On the Benefits of USMCA: Vilsack Testifies
ICYMI: Inside The Pharmaceutical Lobby's Campaign For More Government Subsidies Through Medicare Part D
Grassley Commemorating National Whistleblower Appreciation Day
Grassley Statement on Newly-Released GAO Report on Medicaid Supplemental Payments
Grassley on Spread Pricing
Op-Ed: Trump’s Changes To Investor Visa Program Are A Win For Rural America
Capitol Hill Report
The Benefits of USMCA
Grassley to Hold Town Meetings in Sac and Cherokee Counties
Grassley Statement on HUD Initiative to Help Foster Youth
Grassley’s Rx Bill Passes: “Unprecedented,” “Historic,” “Blockbuster,” “Tipping Point,” “Sweeping,” “Ambitious,” “Major”
Grassley Statement on Committee Passage of Prescription Drug Pricing Reduction Act